We have observed
8 EP applications
has served for within the last five+ years.
(We consider all applications which have an EP A1 or A2 publication dated after December 08, 2013).
Please note, that we only count EP applications,
in which the name of the patent attorney is explicitly mentioned as representative.
These EP applications are:
ASYMMETRICALLY SUBSTITUTED ANTHRAPYRIDAZONE DERIVATIVES AS CYTOSTATICS
MEDICAL MATERIAL, THE METHOD OF ITS PRODUCTION AND USE OF THE MEDICAL MATERIAL
MEDICAL MATERIAL FOR RECONSTRUCTION OF BLOOD VESSELS, THE METHOD OF ITS PRODUCTION AND USE OF THE MEDICAL MATERIAL FOR RECONSTRUCTION OF BLOOD VESSELS
USE OF A MIR172 MOLECULE FOR DECREASING INFLAMMATION
ANTIGEN, INFLUENZA VACCINE, SYSTEM FOR VACCINE MANUFACTURING, METHOD OF ANTIGEN PRODUCTION, AND USE OF ANTIGEN TO PRODUCE AN INFLUENZA VACCINE
USE OF CATIONIC DERIVATIVES OF POLYPRENOLS PTAI IN PRODUCTION OF IMMUNOMODULATING SUBSTANCES
A FACTOR INCREASING EFFICIENCY OF A DNA VACCINE AGAINST A VIRUS, A PLASMID DNA FORMULATION, A DNA VACCINE, A METHOD OF OBTAINING A MODIFIED EXPRESSION VECTOR AND USE OF A NUCLEOTIDE SEQUENCE RECOGNISED BY THE NF KAPPA B FACTOR
A METHOD OF OBTAINING LIQUID BIOHYDROCARBONS FROM OILS OF NATURAL ORIGIN